Albus Health featured in The Pharma Navigator’s latest coverage on the future of clinical trial measurement. In the piece, CEO Mikesh Udani highlights how Albus Health’s passive, non‑contact respiratory monitoring technology is helping the industry move beyond burdensome, manual data collection toward richer, more continuous, patient‑centric insights.

His perspective underscores a growing shift across life sciences: measuring what truly matters to patients while reducing friction in trial participation. You can listen to, and read the article here.